Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (161-170 of 415) with videos related to

Pageof 42
Sort By:
Frontiers in Medicine|October 17, 2019
Next-Generation Sequencing for the Diagnosis of Challenging Culture-Negative EndocarditisManon Kolb, Vladimir Lazarevic, Stéphane Emonet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewNathan Ford, Zara Shubber, Alexandra Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
HIV viral load monitoring in resource-limited regions: optional or necessary?Alexandra Calmy, Nathan Ford, Bernard Hirschel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2022
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort StudyFrédérique Chammartin, Katharine Darling, Irene A Abela, et al.
AIDS (London, England)|January 25, 2013
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysisZara Shubber, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
Frontiers in Immunology|February 28, 2022
Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected IndividualsVera Portillo, Chiara Fedeli, Pilar Ustero Alonso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaTristan Ferry, Bernard Hirschel, Thanh Dang, et al.
Clinical Pharmacokinetics|February 18, 2018
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesNiloufar Marsousi, Youssef Daali, Pierre Fontana, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in CameroonChristian Laurent, Anke Bourgeois, Eitel Mpoudi-Ngolé, et al.
Pageof 42

Showing results (161-170 of 415) with videos related to

Sort By:
Pageof 42
Frontiers in Medicine|October 17, 2019
Next-Generation Sequencing for the Diagnosis of Challenging Culture-Negative EndocarditisManon Kolb, Vladimir Lazarevic, Stéphane Emonet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewNathan Ford, Zara Shubber, Alexandra Calmy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
HIV viral load monitoring in resource-limited regions: optional or necessary?Alexandra Calmy, Nathan Ford, Bernard Hirschel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2022
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort StudyFrédérique Chammartin, Katharine Darling, Irene A Abela, et al.
AIDS (London, England)|January 25, 2013
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysisZara Shubber, Alexandra Calmy, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
Frontiers in Immunology|February 28, 2022
Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected IndividualsVera Portillo, Chiara Fedeli, Pilar Ustero Alonso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaTristan Ferry, Bernard Hirschel, Thanh Dang, et al.
Clinical Pharmacokinetics|February 18, 2018
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesNiloufar Marsousi, Youssef Daali, Pierre Fontana, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in CameroonChristian Laurent, Anke Bourgeois, Eitel Mpoudi-Ngolé, et al.
Pageof 42